about
Criteria for validation of methods in microbial forensicsGuidelines for the identification of unknown samples for laboratories performing forensic analyses for chemical terrorismLiquid chromatography-tandem mass spectrometry for analysis of intestinal permeability of loperamide in physiological bufferSimultaneous LC-MS/MS determination of JWH-210, RCS-4, ∆(9)-tetrahydrocannabinol, and their main metabolites in pig and human serum, whole blood, and urine for comparing pharmacokinetic data.Liquid Chromatography with a Fluorimetric Detection Method for Analysis of Paralytic Shellfish Toxins and Tetrodotoxin Based on a Porous Graphitic Carbon ColumnQuantitative analysis of adenosine using liquid chromatography/atmospheric pressure chemical ionization-tandem mass spectrometry (LC/APCI-MS/MS)Validated method for the determination of ethylglucuronide and ethylsulfate in human urine.Pharmacokinetics of artesunate alone and in combination with sulfadoxine/pyrimethamine in healthy Sudanese volunteersAnalyses of benzodiazepines and their metabolites in various biological matrices by LC-MS(/MS).Turbulent flow chromatography in bioanalysis: a review.Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib.Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.A Fatal Case of Pentedrone and α-Pyrrolidinovalerophenone Poisoning.Analysis of Amphetamine-Derived Designer Drugs by Gas Chromatography with Mass Spectrometry.Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples.Rapid and simultaneous determination of multiple classes of abused drugs and metabolites in human urine by a robust LC-MS/MS method - application to urine drug testing in pain clinics.Development and validation of a sensitive UHPLC-MS/MS method for the simultaneous analysis of tramadol, dextromethorphan chlorpheniramine and their major metabolites in human plasma in forensic context: application to pharmacokinetics.Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.Compound identification in forensic toxicological analysis with untargeted LC-MS-based techniques.Development and Validation of a GC-MS Method for the Detection and Quantification of Clotiapine in Blood and Urine Specimens and Application to a Postmortem CaseSuccessful adaption of a forensic toxicological screening workflow employing nontargeted liquid chromatography-tandem mass spectrometry to water analysis.Development and evaluation of a hydrophilic interaction liquid chromatography-MS/MS method to quantify 19 nucleobases and nucleosides in rat plasma.Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.Fast and sensitive analysis of beta blockers by ultra-high-performance liquid chromatography coupled with ultra-high-resolution TOF mass spectrometry.Phosphorothioate oligonucleotide quantification by μ-liquid chromatography-mass spectrometry.Biomarker method validation in anticancer drug developmentQuantitative determination of fatty acids in marine fish and shellfish from warm water of Straits of Malacca for nutraceutical purposes.Validated LC-MS-MS Method for Multiresidual Analysis of 13 Illicit Phenethylamines in Amniotic Fluid.The development of multiple probe microdialysis sampling in the stomachCannabinoid stability in authentic oral fluid after controlled cannabis smoking.Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methyleneValidated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-mePharmacokinetics of heroin and its metabolites in vitreous humor and blood in a living pig model.Thyronamines are isozyme-specific substrates of deiodinases.Collection of biological samples in forensic toxicology.Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review.The analysis of antipsychotic drugs in human matrices using LC-MS(/MS).Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities.
P2860
Q23910592-D892A9D6-A48E-4762-9D69-2D36FD02CDE1Q23918037-592BD43C-D94F-4315-B2CF-827288949BFEQ28485106-BF155332-DECC-47CB-8C75-F6C2D8F96AE5Q30910292-2E1C81E6-55F4-4557-9B7F-F1BAD6F671ACQ31111828-823B59B9-445A-4234-B43B-8AD528C1A133Q33446142-8A2731FB-5BFC-45E8-8FE5-3B6C7A68D3C9Q33449209-BAE5A906-7039-4F88-9B5B-7995F6589B06Q33719587-BF3FB035-14F5-4B04-BFD5-AEC586B3038CQ33844976-EA608AC5-9C58-4FE8-ADBB-D2EFEAAF70AAQ34317104-A2CC5CCF-F105-44A9-AAB1-390A5601F7DBQ34377463-FEE4A187-B7EE-4200-8873-B95E8362B569Q34451894-256A2D4A-4BC3-4B7D-B919-72D060FC8994Q34465568-7218C7E7-C93C-430F-9084-DBC52B3C9E8AQ34497300-989430CA-95F4-4AA6-B0C3-6C94ACFA5AC2Q34533785-CB8E5C5A-B003-4743-9AC8-57A591FDCCA0Q34777764-390A283D-9EE7-4583-A136-942E2CB1E2E9Q35444405-63ABFB9C-5659-4489-9976-1AE37FDCDF29Q35536635-A8EDF0DC-39F2-41D1-BA47-3F3570AAECD7Q35635675-FEC4D8BF-58E3-4C27-8581-1C1F2F4FEFD8Q35840290-960A8143-28C1-417C-A909-F8DFE6883C89Q35868798-9B1314AE-BD03-45A9-BD55-BDFAAC7E83A0Q35899374-A66FD666-4550-47FA-BA60-29C83E2057A7Q36151663-FAE67C0B-0F99-49D6-BFB1-B2442D476CCAQ36169726-CFCEAB02-68C6-45ED-8D55-B4BC0654C79CQ36214769-E580D7EA-C3EB-4616-8528-403BC06E9B4FQ36331548-2C930CB8-57DF-44BF-9737-003D1F35972CQ36484621-53E8B7AA-D6E3-42CF-B87F-CDFF32A10A4BQ36665128-313CC4F1-D93A-48ED-AAE4-A6E68B86B079Q36948814-2E90A76A-7B19-45D2-B0A5-94A625CC58B9Q36953678-00BAD97B-D082-4AF0-8308-CED0F1E0BDD3Q37029564-88FC2724-F63A-4E45-BF35-E02A01D72DEBQ37161392-EA74D0EE-AC4C-46D2-8CBD-75BCB24D6549Q37193466-16861E92-418F-4FB0-B0E8-03E53CBCED6FQ37245923-BC136167-D042-4EA5-AC47-72F821AA6D6FQ37325285-09E2D660-52D3-4402-96F2-15C0457AB15AQ37771033-A341BB27-8791-4898-B129-D0EA3F5FEEC0Q37866806-527CCB92-5394-4AAD-B6E1-4F2C2E5EA745Q38006891-2EF9FE35-95C4-424C-AAE7-F85AD57BF4CBQ38008991-47829004-8B1B-410C-8ADB-65C2C7B27A0CQ38128797-AAE03981-4F79-4D41-904A-87C41FFC6879
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Validation of new methods.
@ast
Validation of new methods.
@en
type
label
Validation of new methods.
@ast
Validation of new methods.
@en
prefLabel
Validation of new methods.
@ast
Validation of new methods.
@en
P1476
Validation of new methods.
@en
P2093
Frank T Peters
P304
P356
10.1016/J.FORSCIINT.2006.05.021
P577
2006-06-16T00:00:00Z